Editorial: Advancing reproductive outcomes: integrating molecular, metabolic, and endocrine insights into oocyte maturation

• by Konstantinos Dafopoulos

• May 13, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

Abdominal complete hydatidiform mole following uterine evacuation: a case report

• by Zeqing Du, Shizhao Wang

• May 13, 2026

Fetal growth in PCOS pregnancies: dynamic evidence of restriction and the modifying role of ART

• by Heze Xu, Yijia Liu, Xinyi Bian, Zhijiao Wang, Zhen Li, Hang Zhen, Shanwei Xing, Jingshuang Zhou, Zekai Bai, Jiapo Li, Chong Qiao

• July 15, 2026